OB/GYN Clinical Alert – September 1, 2021
September 1, 2021
View Issues
-
Is Black Race Associated with Major Depression Following Early Pregnancy Loss?
Reporting symptoms of having major depression one month after treatment for early pregnancy loss was about twice as common among Black women compared to non-Black women.
-
Ketamine Use in the Prevention of Postpartum Depression Is Premature
A double-blinded, randomized clinical trial of 134 low-risk pregnant women in Iran undergoing scheduled cesarean deliveries was conducted to address if a single dose of ketamine during anesthesia induction has a role in the prevention of postpartum depression. The authors reported that depression scores using the Edinburgh Postnatal Depression Scale at two and four weeks after the cesarean delivery were significantly lower in the ketamine group vs. the control group.
-
Evaluation and Treatment of Women with Symptoms of Recurrent UTIs
Only 33% of women presenting to a urogynecology practice with symptoms of recurrent urinary tract infections met diagnostic criteria for recurrent urinary tract infections. The use of preventive strategies can be improved.
-
LMWH vs. UFH in Pregnant Women Undergoing Anticoagulation
In this retrospective cohort study of pregnant women treated with low-molecular-weight heparin (LMWH) alone compared to those switched to unfractionated heparin (UFH) in the peripartum period, the outcomes were similar in both groups.
-
OB/GYN Clinical Alert Welcomes Maria F. Gallo, PhD
Maria F. Gallo, PhD, joins OB/GYN Clinical Alert.